Immuron (IMRN) Other Non Operating Income (2017 - 2023)
Immuron (IMRN) posted quarterly Other Non Operating Income of $4441.0 for Q4 2023, up 629.95% year-over-year from $608.4 in Q4 2022, and up 629.95% quarter-over-quarter from -$838.0 in Q4 2022.
Immuron (IMRN) Other Non Operating Income (2017 - 2023) Analysis & Trends
Immuron's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $4441.0 for Q4 2023.
- In Q4 2023, Other Non Operating Income rose 629.95% year-over-year to $4441.0; the TTM figure through Dec 2023 stood at $3455.9 (up 382.41% YoY), while the FY2023 annual figure was -$674.01, changed N/A from the prior year.
- Other Non Operating Income for Q4 2023 stood at $4441.0, up from -$838.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $4441.0 in Q4 2023, with the low at -$838.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is -$150.57 (2020), against an average of $643.46.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income plunged 24508.97% in 2022, then surged 629.95% in 2023.
- Immuron's Other Non Operating Income stood at -$238.57 in 2019, then soared by 36.89% to -$150.57 in 2020, then soared by 102.28% to $3.43 in 2021, then tumbled by 24508.97% to -$838.0 in 2022, then soared by 629.95% to $4441.0 in 2023.
- Business Quant data shows IMRN's Other Non Operating Income at $4441.0 in Q4 2023, -$838.0 in Q4 2022, and $3.43 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4,441.00 |
| Dec 31, 2022 | -838.00 |
| Dec 31, 2021 | 3.43 |
| Dec 31, 2020 | -150.57 |
| Dec 31, 2019 | -238.57 |
| Dec 31, 2018 | -112,270.00 |
| Dec 31, 2017 | -46,380.23 |